Loading...
Humana Inc.
0J6Z.L•LSE
Healthcare
Medical - Equipment & Services
£246.16
£-8.87(-3.48%)
Humana Inc. (0J6Z.L) Financial Performance & Income Statement Overview
Review Humana Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.70%
↑ 10.70%
Operating Income Growth
-36.16%
↓ 36.16%
Net Income Growth
-51.51%
↓ 51.51%
Operating Cash Flow Growth
-25.50%
↓ 25.50%
Operating Margin
2.20%
↑ 2.20%
Gross Margin
75.19%
↑ 75.19%
Net Profit Margin
1.02%
↑ 1.02%
ROE
7.23%
↑ 7.23%
ROIC
5.59%
↑ 5.59%
Humana Inc. (0J6Z.L) Income Statement & Financial Overview
Review Humana Inc.'s (0J6Z.L) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $32.11B | $29.21B | $29.40B | $29.54B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $32.11B | $29.21B | $29.40B | $29.54B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $3.84B | $3.28B | $3.08B |
| Operating Expenses | $30.10B | $29.76B | $28.67B | $28.40B |
| Total Costs & Expenses | $30.10B | $29.76B | $28.67B | $28.40B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $160.00M | $164.00M | $169.00M | $168.00M |
| Depreciation & Amortization | $215.00M | $240.00M | $243.00M | $243.00M |
| EBITDA | $2.07B | -$303.00M | $971.00M | $1.38B |
| EBITDA Ratio | $0.06 | -$0.01 | $0.03 | $0.05 |
| Operating Income | $2.01B | -$543.00M | $728.00M | $1.14B |
| Operating Income Ratio | $0.06 | -$0.02 | $0.02 | $0.04 |
| Other Income/Expenses (Net) | -$366.00M | -$356.00M | -$93.00M | -$240.00M |
| Income Before Tax | $1.65B | -$899.00M | $635.00M | $901.00M |
| Income Before Tax Ratio | $0.05 | -$0.03 | $0.02 | $0.03 |
| Income Tax Expense | $406.00M | $216.00M | $155.00M | $223.00M |
| Net Income | $1.24B | -$693.00M | $480.00M | $679.00M |
| Net Income Ratio | $0.04 | -$0.02 | $0.02 | $0.02 |
| EPS | $10.31 | -$5.75 | $3.99 | $5.64 |
| Diluted EPS | $10.30 | -$5.76 | $3.98 | $5.63 |
| Weighted Avg Shares Outstanding | $120.41M | $120.41M | $120.41M | $120.44M |
| Weighted Avg Shares Outstanding (Diluted) | $120.76M | $120.76M | $120.76M | $120.67M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan